Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 15 (2), 80-6

Genetic Aspects of Alzheimer Disease

Affiliations
Review

Genetic Aspects of Alzheimer Disease

Jennifer Williamson et al. Neurologist.

Abstract

Background: Alzheimer disease (AD) is a genetically complex disorder. Mutations in 3 genes, presenilin 1, amyloid precursor protein, and presenilin 2, lead to early-onset familial AD in rare families with onset of disease occurring prior to age 65. Specific polymorphisms in apolipoprotein E are associated with the more common, late-onset AD occurring after age 65. In this review, we discuss current advances in AD genetics, the implications of the known AD genes, presenilin 1, presenilin 2, amyloid precursor protein, and apolipoprotein E, and other possible genes on the clinical diagnosis, treatment, and genetic counseling of patients and families with early- and late-onset AD.

Review summary: In addition to the mutations in 4 known genes associated with AD, mutations in other genes may be implicated in the pathogenesis of the disease. Most recently, 2 different research groups have reported genetic association between 2 genes, sortilin-related receptor and GAB2, and AD. These associations have not changed the diagnostic and medical management of AD.

Conclusions: New research in the genetics of AD have implicated novel genes as having a role in the disease, but these findings have not been replicated nor have specific disease causing mutations been identified. To date, clinical genetic testing is limited to familial early-onset disease for symptomatic individuals and asymptomatic relatives and, although not recommended, amyloid precursor protein apolipoprotein E testing as an adjunct to diagnosis of symptomatic individuals.

Figures

FIGURE 1
FIGURE 1
Clinical genetic gecision making for Alzheimer disease.

Similar articles

  • [Genetics of Late-Onset Alzheimer's Disease: Vascular Risk and Beta-Amyloid Metabolism]
    F Panza et al. Recenti Prog Med 93 (9), 489-97. PMID 12355988. - Review
    Progress in clinical and basic research of Alzheimer's disease (AD) suggested theoretical models of possible pathogenetic mechanisms, with a primary role of the genetic f …
  • The Current Status of Alzheimer's Disease Genetics: What Do We Tell the Patients?
    L Bertram et al. Pharmacol Res 50 (4), 385-96. PMID 15304236. - Review
    Alzheimer's disease (AD) is a genetically complex and heterogeneous disorder. Fully penetrant (causal) mutations leading to predominantly early-onset familial AD have bee …
  • Exploring the Etiology of Alzheimer Disease Using Molecular Genetics
    CL Lendon et al. JAMA 277 (10), 825-31. PMID 9052714. - Review
    Alzheimer disease (AD), the most common cause of dementia in the elderly, exists in both familial and sporadic forms. Genetic studies have led to the identification of 3 …
  • [Genes in Alzheimer's Disease]
    J Hoenicka. Rev Neurol 42 (5), 302-5. PMID 16538594. - Review
    Although the APOE epsilon4 allele is the only proven genetic risk factor for the late form of the disease, genetic epidemiological studies suggest that other loci are als …
  • Genetic Aspects of Alzheimer's Disease
    C Zekanowski et al. Acta Neurobiol Exp (Wars) 64 (1), 19-31. PMID 15190677. - Review
    Alzheimer's disease (AD) is a neurodegenerative disorder with a complex etiology and pathogenesis. Mutations in presenilin 1 gene (PSEN1), located on chromosome 14, more …
See all similar articles

Cited by 18 PubMed Central articles

See all "Cited by" articles
Feedback